Plain-English translation of NCT06315673 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial examined whether digital assessments of speech and fine motor control—such as recording how someone speaks or measuring handwriting patterns—could provide a more detailed picture of how ALS and related motor neuron diseases progress. The researchers collected speech and handwriting samples from people with ALS, primary lateral sclerosis, or progressive muscular atrophy, as well as from healthy volunteers, and compared the digital measurements to standard clinical assessments.
Doctors currently use a questionnaire called the ALSFRS-R to track how ALS affects patients over time, but this tool can be too general and may miss small but important changes in how people speak or use their hands. This trial was designed to explore whether detailed digital measurements could catch these changes more accurately and help clinicians monitor disease progression better.
Participants attended a single study visit where they completed digital assessments of their speech and fine motor control—for example, they recorded themselves speaking and provided handwriting samples that were analyzed by computer. The trial also included healthy control volunteers without neurological conditions who completed the same assessments so researchers could compare the results. The entire process took place at one visit and involved no medications or invasive procedures.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
United States